Nine patients with coupled ventricular premature depolarizations (VPDs) were treated with intravenous procaine amide to abolish the arrhythmia. The effect of procaine amide on the electrocardiogram was carefully observed. Seven 
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VPDs becomes progressively longer until the arrhythmia is abolished. We believe this electrocardiographic observation results from procaine amide's electrophysiologic properties, and in turn, is responsible for its antiarrhythmic effect. Our goal is to characterize the phenomenon of an increasing coupling interval with procaine amide therapy and to provide a hypothesis for procaine amide's mechanism of action against human re-entrant ventricular arrhythmias.
Methods and Materials
Nine patients wih coupled VPDs admitted to the Cardiac Intensive Care Unit were studied (table 1) . Three patients had arteriosclerotic heart disease with acute myocardial infarction, two had arteriosclerotic heart disease associated with angina or previous myocardial infarction, three had heart disease of unknown etiology and one had rheumatic heart disease. Three patients were on maintenance digoxin but the cause of their arrhythmia was not felt to be digitalis induced; all had normal plasma potassium and calcium; two patients had an elevated blood urea nitrogen. In each case the patient's physician elected to treat the arrhythmia based on electrocardiographic evidence for frequent VPDs Abbreviationis: ASH) = arteriosclerotic heart disease; EH = enlarged heart; AMI = acute myocardial iinfarction; LVF = left ventricular failure (determined by physical examination and/or chest X-ray); RHD = PROCAINE AMIDE doses every five minutes or to maintain constant intravenous infusion and only discontinue the drug if 1) the arrhythmia was abolished, 2) 1,000 mg cumulative dose had been given, or 3) undesirable drug effects were encountered. In patients receiving infusioIns, the infusion rate was reduced or discontinued as soon as arrhythmia was abolished in order to avert untoward drug effects. Throughout the study a blood sample for procaine amide plasma concentration was obtained during the 4.5 to 5 minute period after each drug dose for the seven patients who received 100 mg every five minutes; and during every 4.5 to 5 minutes for the first 30 minutes and every ten minutes thereafter for those who received constant infusion. Arterial blood pressure was determined by cuff syphgmomanometer at the same time plasma samples were taken. Two methods of drug administration were used because we had considered the possibility that the method of drug administration might alter the drug disposition and thereby the pattern of therapeutic response. Drug disposition in the body often satisfactorily fits a two compartment model.8' 9 Figure 1 shows the procaine amide concentration time curves of the central and peripheral compartments predicted by a two compartment model for the two methods of administration used in this study. In order to determine which of the possible patterns of behavior of drug effect and concentration shown in figure 2 were applicable after a rapid intravenous injection, the first five-minute interval in which the number of VPDs was reduced by at least 50% was analyzed. This interval was divided into five one-minute periods and the average coupling interval was determined for each minute. Three models are possible for the behavior of VPDs depending on whether the arrhythmic site in the myocardium is in the central ( The Figure 2 Possible behavior of the VPD coupling interval in three models of drug concentration and effect at the site of origin of the arrhythmia after a rapid intravenous injection. A) If the procaine amide concentration at the arrhythmic focus in the heart follows drug concentration in the central compartment, changes in coupling interval would be greatest almost instantly following drug injection and become less marked during the following five minute interval. B) If drug concentration at the arrhythmic focus follows drug concentration in the slower equilibrating total peripheral compartment, the coupling interval should progressively increase over the five minute time course following drug injection. C) If the arrhythmic focus behaves like a compartment that equilibrates faster than the total peripheral compartment, changes in coupling interval increase but then decrease during the five minute interval. A rapid phase of distribution to the heart (if the fast phase has a ti2 of one and a half minutes rather than eight minutes) would produce early myocardial changes. These alterations might decrease once an equilibrium between the heart and central compartment was established and drug distribution to the slower equilibrating total peripheral compartment takes place.
(panel B), or a rapidly equilibrating peripheral compartment (panel C) ( fig. 2 ). If the myocardium equilibrates with the central compartment (C in fig. 1 ) at the same rate as the total peripheral compartment its concentration time course would be described by line P (in fig. 1 ). If, however, the myocardium equilibrates more rapidly than the average peripheral compartment it could be described by the theoretical line P1 ( fig. 1 ). Counting every ectopic depolarization by hand and by computer analysis during the control period and during drug therapy validated the finding that VPDs were completely suppressed by procaine amide. Figure 3 , a computer print out from a typical patient, shows two minute periods before drug administration and after 600 mg procaine amide had been administered. This print out recorded just prior to arrhythmia abolition documents the reduced frequency of VPDs. However, from the initiation of drug therapy a graded decrease in A number of VPDs was observed ( Each black point in the graph represents one R-R interval in msec before administration of drug (A), and after 600 mg of procaine amide (B) for patient J.K. The sinus cycle length (R-R) (middle series of black points), coupling interval of VPD (R-V) (bottom series of black points) and compensatory pause (V-R') (top series) from the surface electrogram are shown in the top two panels. The intervals also measured by hand agree with the values from the print out. In panel A, before drug treatment, the R-R interval is 820 msec; followed by a ventricular premature depolarization, R-V of 480 msec; and a compensatory pause, V-B', of more than 1000 msec. The thin vertical line at the end of the graph in panel A is a reference point and is the mean control coupling interval determined for this time interval. In panel B, at a drug concentration of 6.5 ,ug/ml the coupling interval on the surface ECG had increased to 580-590 from 480 msec. From the graph it is apparent that ventricular premature depolarizations are less frequent and more variable and that sinus rate has not been significantly altered. The dashed horizontal line indicating a new mean coupling interval for all ventricular extrasystoles in this five minute period is 90 msec longer than the control. No difference in magnitude of change of the coupling interval could be discerned at the termination of arrhythmia as a result of different methods of drug administration (fig. 4) . For the seven patients treated with repeated intravenous injections of procaine amide, the maximum average coupling interval increased by 37 to 100 msec; for the two treated with constant intravenous infusion, the maximum average coupling interval increased by 70 to 100 msec. The average change for all patients was 66 msec (P < 0.001) (table 3).
Compartmental Analysis after Intravenous Procaine Amide
We considered the possibility that sudden intravenous injection of procaine amide might alter drug disposition in such a way that drug is presented to the heart differently than after a constant intravenous infusion ( fig. 2) ECG Intervals. The drug effect on the P-R, QRS, and Q-T intervals was variable and did not appear related to pre-existing abnormalities of these intervals (table 3) .
P-R Interval. In five patients, P-R interval increased by a maximum of 5 to 20 msec; in four patients there was no change. One patient had a normal control P-R which became abnormally prolonged after procaine amide. Mean increase in P-R interval of 6.6 msec was statistically significant (P<0.05).
QRS Interval. In three patients there was no change in duration of QRS and in six patients QRS increased by a maximum of 10 to 15 msec. The mean increase in QRS of 6.6 msec was statistically significant (P<0.01). No patient developed QRS widening more than 30% of control.
Q-T Interval. Q-T interval increased in six patients by 20 to 30 msec and in three patients was not changed after drug therapy. The mean increase in Q-T interval of 14.4 msec was not statistically significant.
Discussion
Although procaine amide has been in clinical use for more than 20 years," 2 its mechanism of action against ventricular arrhythmias in man is not completely understood. One reason for this is that often the mechanism for the arrhythmia is not entirely clear. Understanding the mode of action of an antiarrhythmic drug requires knowledge of the mechanism by which the arrhythmia in question is initiated and maintained as well as an awareness of the cardiac effects of the drug.5
In simple terms, arrhythmias are caused by either disorders of conduction or automaticity or a combination of these.10 Well-established electrocardiographic criteria have been used to differentiate the origin of arrhythmias. Traditionally a premature depolarization which bears a consistent temporal relationship to the sinus depolarization preceding it, i.e., a coupled premature depolarization, is thought to be a passive phenomenon precipitated by the preceding depolarization."' 12 This general thesis is supportable on both experimental and theoretical grounds. It is based on the historical observation that a single mechanical or electrical stimulus applied to the heart may elicit one or more subsequent contractions'3' 14' 15 20 Although we recognize that mechanisms other than simply reentry, e.g., afterpotentials or oscillations, could generate coupled VPDs, we will assume for the purposes of this analysis that coupled VPDs are due to re-entry and will attempt to explain the effect of procaine amide on coupled VPDs in man using the Schmitt-Erlanger model.
Continuous computer analysis of the ECG before and during drug therapy allowed the frequency of VPDs and every R-R interval to be measured. In addition, we measured plasma procaine amide concentrations during drug therapy. As a result of this analysis, we observed an interesting electrocardiographic phenomenon. In every patient, as plasma procaine amide concentration increased not only did the frequency of the VPDs decrease but their coupling interval increased as well (fig. 4) Antiarrhythmic plasma concentrations of procaine amide produce some prolongation of the P-R, QRS, and Q-T intervals in man.7 These electrocardiographic changes show that procaine amide produces conduction delay outside the site of origin of the arrhythmia, in man (table 3) . Procaine amide should produce even more profound effects on focal depressed zones responsible for the VPDs.
Given the Schmitt-Erlanger model, the mechanism of action of procaine amide proposed in figure 6 is the only reasonable explanation for our observa figure 6 is the most reasonable way to account for lengthening of the coupling interval of coupled VPDs and to explain procaine amide's mode of action against human re-entrant ventricular arrhythmias.
